2 episodes on Huberman Lab
Dr. Matthew Johnson is a senior researcher at the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt's Institute for Advanced Diagnostics and Therapeutics. He is a leading expert in psychedelic neuroscience and clinical research, investigating the therapeutic potential of substances like psilocybin, MDMA, and LSD for treating mental health disorders.
Psychedelics including psilocybin, MDMA, and LSD work by altering perception and self-representation in the brain, with lasting therapeutic effects when used in controlled clinical settings
Clinical research demonstrates psilocybin and MDMA show significant therapeutic potential for treating depression, addiction, PTSD, and other mental health disorders